Author: Hongyi Chen; Zhicheng Zhang; Li Wang; Zhihua Huang; Fanghua Gong; Xiaodong Li; Yahong Chen; Jinzi J. WU
Title: First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Document date: 2020_3_24
ID: b3y9zxjr_9
Snippet: Pugh score ≥ C, AST > 5 times upper limit); patients with contraindications specified in the label of ritonavir tablets; the pregnancy test of female subjects during the screening period was positive; the researchers judged that the patient was not suitable to participate in this clinical study (for example, patients with multiple basic diseases, etc.)......
Document: Pugh score ≥ C, AST > 5 times upper limit); patients with contraindications specified in the label of ritonavir tablets; the pregnancy test of female subjects during the screening period was positive; the researchers judged that the patient was not suitable to participate in this clinical study (for example, patients with multiple basic diseases, etc.).
Search related documents:
Co phrase search for related documents- basic disease and multiple basic disease: 1, 2
- clinical study and pregnancy test: 1, 2, 3, 4
- clinical study and pugh score: 1
- clinical study and ritonavir tablet: 1
- clinical study and screening period: 1, 2, 3, 4, 5, 6
- clinical study and upper limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- pregnancy test and pugh score: 1
- pregnancy test and screening period: 1
- pregnancy test and upper limit: 1, 2, 3, 4
- pugh score and screening period: 1
- pugh score and upper limit: 1, 2
- screening period and upper limit: 1
Co phrase search for related documents, hyperlinks ordered by date